New User? Sign Up | Sign In

Insider Trading - Denali Therapeutics Inc. (DNLI)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
DNLI Insider Trading Transactions for Denali Therapeutics Inc.
Goto page 0, 1, 2, 3, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-03-30
Sale
2020-04-01
6:19 pm
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
1,428 $19.48 $27,817 1,006,488
(Direct)
View
2020-06-05
Sale
2020-06-09
4:10 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Crestline SI (GP) L.P.
Crestline Investors Inc.
Crestline Management LP
10% Owner
1,922,855 $25.75 $49,513,516 13,644,881
(Indirect)
View
2020-06-16
Sale
2020-06-18
9:41 pm
Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director
400,000 $26.1 $10,440,000 2,739,043
(Direct)
View
2020-06-19
Sale
2020-06-23
5:41 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
Neuro Line Partners LP
Bratton Capital Management L.P.
Bratton Capital Inc.
10% Owner
255,000 $24.72 $6,304,373 698,035
(Indirect)
View
2020-06-26
Sale
2020-06-30
7:17 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
Neuro Line Partners LP
Bratton Capital Management L.P.
Bratton Capital Inc.
10% Owner
250,000 $23.97 $5,993,052 448,035
(Indirect)
View
2020-08-12
Sale
2020-08-14
4:50 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Crestline SI (GP) L.P.
Crestline Investors Inc.
Crestline Management LP
10% Owner
1,443,247 $31.65 $45,678,767 12,201,634
(Indirect)
View
2020-09-10
Sale
2020-09-14
9:38 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
3,689 $31 $114,359 165,141
(Indirect)
View
2020-10-08
Sale
2020-10-13
6:45 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
52,906 $40.74 $2,155,603 166,617
(Indirect
Direct)
View
2020-11-04
Sale
2020-11-06
5:53 pm
Denali Therapeutics Inc. DNLI Schenkein David P
Director
10,000 $50.18 $501,830 65,000
(Indirect
Direct)
View
2020-11-10
Sale
2020-11-12
4:21 pm
Denali Therapeutics Inc. DNLI Schenkein David P
Director
10,000 $60.03 $600,310 55,000
(Indirect
Direct)
View
2020-11-12
Sale
2020-11-13
5:13 pm
Denali Therapeutics Inc. DNLI Schenkein David P
Director
30,000 $70.05 $2,101,590 25,000
(Indirect
Direct)
View
2018-11-15
Sale(A)
2020-11-30
6:12 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $18.07 $316,157 178,125
(Indirect
Direct)
View
2018-12-03
Sale(A)
2020-11-30
6:13 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $18.45 $322,834 178,125
(Indirect
Direct)
View
2019-01-02
Sale(A)
2020-11-30
6:14 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $19.44 $340,168 178,125
(Indirect
Direct)
View
2020-12-11
Sale
2020-12-15
4:47 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
Neuro Line Partners LP
Bratton Capital Management L.P.
Bratton Capital Inc.
10% Owner
64,624 $80.14 $5,179,285 383,411
(Indirect)
View
2020-12-21
Sale
2020-12-23
9:52 pm
Denali Therapeutics Inc. DNLI Schenkein David P
Director
30,000 $90.05 $2,701,582 26,232
(Indirect
Direct)
View
2021-01-04
Sale
2021-01-06
6:49 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
88,334 $74.96 $6,621,782 2,322,978
(Indirect
Direct)
View
2021-01-04
Sale
2021-01-06
6:50 pm
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
70,000 $74.95 $5,246,409 544,562
(Indirect
Direct)
View
2021-01-15
Sale
2021-01-20
6:46 pm
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
50,000 $71.45 $3,572,556 950,000
(Indirect
Direct)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-06-03
Option Award
2020-06-05
5:58 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Cole Douglas G.
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:58 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Cole Douglas G.
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:59 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Cook Jennifer E.
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:59 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Cook Jennifer E.
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:00 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI FLATLEY JAY T
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:00 pm
N/A
N/A
Denali Therapeutics Inc. DNLI FLATLEY JAY T
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:00 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:00 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:01 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Klein Peter S
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:01 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Klein Peter S
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:02 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI NELSEN ROBERT
Director
10% Owner
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:02 pm
N/A
N/A
Denali Therapeutics Inc. DNLI NELSEN ROBERT
Director
10% Owner
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:02 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Schenkein David P
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:02 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schenkein David P
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:03 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI SATO VICKI L
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:03 pm
N/A
N/A
Denali Therapeutics Inc. DNLI SATO VICKI L
Director
3,253 $0 3,253
(Direct)
View
2020-06-18
Gift
2020-06-18
9:42 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
40,000 $0 2,389,304
(Indirect)
View
2020-08-18
Option Award
2020-08-20
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
20,000 $0 20,000
(Direct)
View
2020-08-18
Option Award
2020-08-20
6:17 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
20,000 $0 20,000
(Direct)
View
2020-08-18
Option Award
2020-08-20
6:19 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
20,000 $0 20,000
(Direct)
View
2020-08-18
Option Award
2020-08-20
6:20 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
20,000 $0 20,000
(Direct)
View
2020-08-20
Exercise
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
5,643 $0 0
(Indirect)
View
2020-08-20
Tax Withholding
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
1,954 $32.87 0
(Indirect)
View
2020-08-20
Exercise
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
5,643 $0 0
(Direct)
View
2020-08-20
Exercise
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
5,643 $0 0
(Indirect)
View
2020-08-20
Tax Withholding
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
1,954 $32.88 0
(Indirect)
View
2020-08-20
Exercise
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
5,643 $0 0
(Direct)
View
2020-08-20
Exercise
2020-08-24
8:38 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,643 $0 0
(Direct)
View
2020-08-20
Tax Withholding
2020-08-24
8:38 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
1,954 $32.88 0
(Direct)
View
2020-08-20
Exercise
2020-08-24
8:38 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,643 $0 0
(Direct)
View
2020-10-08
Exercise
2020-10-13
6:45 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
22,906 $5.28 166,617
(Indirect)
View
2020-10-08
Exercise
2020-10-13
6:45 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
30,000 $5.28 166,617
(Indirect)
View
2020-10-08
Exercise
2020-10-13
6:45 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
13,020 $5.28 166,617
(Direct)
View
2020-10-08
Exercise
2020-10-13
6:45 pm
N/A
2027-03-07
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
9,886 $5.28 166,617
(Direct)
View
2020-10-08
Exercise
2020-10-13
6:45 pm
N/A
2027-03-07
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
30,000 $5.28 166,617
(Direct)
View
2020-08-20
Exercise
2020-11-30
6:11 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
5,643 $0 614,562
(Indirect)
View
2020-08-20
Tax Withholding
2020-11-30
6:11 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
1,954 $32.88 614,562
(Indirect)
View
2018-11-15
Exercise
2020-11-30
6:12 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
12,235 $5.28 178,125
(Indirect)
View
2018-11-15
Exercise
2020-11-30
6:12 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
12,235 $5.28 178,125
(Direct)
View
2018-12-03
Exercise
2020-11-30
6:13 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $5.28 178,125
(Indirect)
View
2018-12-03
Exercise
2020-11-30
6:13 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $5.28 178,125
(Direct)
View
2019-01-02
Exercise
2020-11-30
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,775 $5.28 178,125
(Indirect)
View
2019-01-02
Exercise
2020-11-30
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,775 $5.28 178,125
(Indirect)
View
2019-01-02
Exercise
2020-11-30
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,950 $5.28 178,125
(Indirect)
View
2019-01-02
Exercise
2020-11-30
6:14 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,775 $5.28 178,125
(Direct)
View
2019-01-02
Exercise
2020-11-30
6:14 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,775 $5.28 178,125
(Direct)
View
2019-01-02
Exercise
2020-11-30
6:14 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,950 $5.28 178,125
(Direct)
View
2020-12-21
Other
2020-12-23
6:44 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
Neuro Line Partners LP
Bratton Capital Management L.P.
Bratton Capital Inc.
10% Owner
383,411 $0 0
(Indirect)
View
2021-01-04
Option Award
2021-01-06
6:49 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
60,000 $0 2,322,978
(Direct)
View
2021-01-04
Option Award
2021-01-06
6:49 pm
N/A
2031-01-03
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
180,000 $70.86 2,322,978
(Direct)
View
2021-01-04
Option Award
2021-01-06
6:50 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
30,000 $0 544,562
(Direct)
View
2021-01-04
Option Award
2021-01-06
6:50 pm
N/A
2031-01-03
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
90,000 $70.86 544,562
(Direct)
View
2021-01-04
Option Award
2021-01-06
6:54 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
30,000 $0 90,000
(Direct)
View
2021-01-04
Option Award
2021-01-06
6:54 pm
N/A
2031-01-03
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
90,000 $70.86 90,000
(Direct)
View
2021-01-04
Option Award
2021-01-06
6:55 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
30,000 $0 90,000
(Direct)
View
2021-01-04
Option Award
2021-01-06
6:55 pm
N/A
2031-01-03
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
90,000 $70.86 90,000
(Direct)
View
2021-01-08
Option Award
2021-01-12
6:44 pm
N/A
2031-01-07
Denali Therapeutics Inc. DNLI Thornberry Nancy
Director
7,535 $80.03 2,511
(Direct)
View
2021-01-08
Option Award
2021-01-12
6:44 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Thornberry Nancy
Director
2,511 $0 2,511
(Direct)
View
Goto page 0, 1, 2, 3, Next